14:00 - 15:15
- 第一阶段：主题报告
- Session I: Keynote Speech
主持人 Moderator
- 杨大俊, 亚盛医药董事长兼首席执行官
- YANG Dajun , Chairman of the Board & CEO of Ascentage Pharma
14:00 - 14:25
- 主题报告1
- Keynote Speech 1
- 中国源头创新破局之路
- The direction of breakthroughs in China's original innovation
- 李进, 中国药科大学附属上海高博肿瘤医院院长
- LI Jin, Director of Shanghai GoBroad Cancer Hospital Affiliated to China Pharmaceutical University
14:25 - 14:50
- 主题报告2
- Keynote Speech 2
- 创新药出海监管变化新趋势及其风险控制
- New trends in regulatory changes and risk control for innovative drugs entering international markets
- 何如意, 上海全球健康创新研究院院长、前国家食品药品监督管理总局药品审评中心首席科学家
- HE Ruyi, CEO of Global Health Innovation Institute, Former Chief Scientist of Center for Drug Evaluation, CFDA
14:50 - 15:15
- 主题报告3
- Keynote Speech 3
- 中国创新药开启肿瘤治疗新思路
- China's innovative drugs open up new maps for cancer treatment
- 林哲安, 台湾医学科学研究基金会董事长
- Che An LIN, Chairman of Foundation for East-Weat Medicine
15:15 - 16:15
- 第二阶段：主题报告
- Session II: Keynote Speech
主持人 Moderator
- 陈刚, 诺思格（北京）医药首席科学官，前美国FDA肿瘤审评中心统计审评部门负责人
- CHEN Gang, CSO of R&G Pharma Studies, Former US FDA Oncology Drug Review Center，Statistical Review Team Leader
15:15 - 15:35
- 主题报告4
- Keynote Speech 4
- 乳腺癌ADC治疗前沿趋势
- Frontier trends in ADC therapy for breast cancer
- 殷咏梅, 江苏省人民医院副院长
- YIN Yongmei, Vice President of Jiangsu Province Hospital
15:35 - 15:55
- 主题报告5
- Keynote Speech 5
- 血液肿瘤耐药领域研发趋势分析
- Analysis of research and development trends in the field of hematological tumor drug resistance
- 张曦, 陆军军医大学新桥医院血液病医学中心主任
- ZHANG Xi, Director of the Hematology Medical Center, Xinqiao Hospital, Army Medical University
15:55 - 16:15
- 主题报告6
- Keynote Speech 6
- 以生物样本活库为抓手推动生物医学新技术临床研究与转化
- Promote clinical research and translation of new biomedical technologies with the core of biological sample biobank
- 闻丹忆, 上海立迪生物技术股份有限公司董事长兼执行总裁
- WEN Danyi, Chairman of the Board & CEO, Shanghai LIDE Biotech Co., Ltd.
16:15 - 17:00
- 第三阶段：主题讨论
- Session III: Panel
主持人 Moderator
- 秦叔逵, 中国药科大学基础医学与临床药学院院长
- QIN Shukui, Dean of School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University
16:15 - 17:00
- 主题讨论
- Panel
- 三医协同推动抗肿瘤新药可持续发展
- Hospitals, medical insurance, and pharmaceutical companies collaborate to promote the sustainable development of new anti-tumor drugs
Panel嘉宾 Panelist
- 邹建军, 君实生物总经理兼首席执行官
- ZOU Jianjun, General Manager and CEO of Junshi Biosciences
- 翟一帆, 亚盛医药首席医学官
- ZHAI Yifan, Chief Medical Officer of Ascentage Pharma
- 吴永谦, 药捷安康董事长兼首席执行官
- WU Yongqian, Chairman and CEO of TransThera Sciences
- 彭伟, 江苏省肿瘤医院副主任医师
- PENG Wei, Deputy Chief Physician of Jiangsu Cancer Hospital
- 王汉明, 武汉滨会生物科技股份有限公司副总经理
- WANG Hanming, Deputy General Manager of Binhui Biopharmaceutical Co., Ltd
Conference Affairs Contact